Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-25 Sale |
2022-10-26 4:41 pm |
PhaseBio Pharmaceuticals Inc | PHAS | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd SANDELL SCOTT D KERINS PATRICK J BASKETT FOREST 10% Owner |
1,784,109 | $0.147 | $262,264 | 4,857,525 (Direct) |
View |
| 2022-05-23 Sale |
2022-05-24 5:14 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen SVP of Human Resources |
11,248 | $0.79 | $8,886 | 0 (Direct) |
View |
| 2021-08-18 Purchase(A) |
2022-05-20 4:47 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
3,000 | $3.08 | $9,240 | 37,760 (Indirect Direct) |
View |
| 2021-11-19 Sale |
2021-11-23 6:50 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
5,766 | $2.37 | $13,665 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-19 Exercise |
2023-05-19 4:18 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | van den Broek Richard Director |
3,750 | $0 | 0 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 4:18 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | van den Broek Richard Director |
3,750 | $0 | 0 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:18 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
3,750 | $0 | 3,581,733 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:18 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Humphries William D. Director |
2,538 | $0 | 2,538 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:17 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | HARRIGAN EDMUND Director |
3,750 | $0 | 9,750 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:17 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
3,750 | $0 | 3,750 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:16 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Loewy Caroline M Director |
3,750 | $0 | 3,750 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:15 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
3,750 | $0 | 41,510 (Direct) |
View |
| 2022-05-19 Option Award(A) |
2022-06-10 4:20 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Humphries William D. Director |
14,380 | $0 | 14,380 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-24 5:15 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth SVP, Technical Operations |
10,917 | $0.6813 | 41,236 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-24 5:14 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
10,918 | $0.6813 | 183,701 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-24 5:14 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen SVP of Human Resources |
11,248 | $0.6813 | 0 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-24 5:13 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Hanson Kristopher SVP and General Counsel |
4,831 | $0.6813 | 8,463 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-24 5:13 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Birchall Jonathan Chief Commercial Officer |
20,000 | $0.6813 | 20,000 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-24 5:12 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
6,026 | $0.6813 | 65,767 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:46 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Humphries William D. Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:46 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:45 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:45 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:44 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Loewy Caroline M Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:44 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | HARRIGAN EDMUND Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:44 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | van den Broek Richard Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:30 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
140,250 | $0 | 140,250 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:27 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
106,250 | $0 | 106,250 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:25 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Birchall Jonathan Chief Commercial Officer |
63,750 | $0 | 63,750 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:23 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Lee John Sang Chief Medical Officer |
140,250 | $0 | 140,250 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:21 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth SVP, Technical Operations |
106,250 | $0 | 106,250 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:19 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Hanson Kristopher VP, Head of Legal |
106,250 | $0 | 106,250 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:14 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
467,500 | $0 | 467,500 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:55 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
5,623 | $2.01 | 172,473 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:54 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth SVP, Technical Operations |
2,559 | $2.01 | 30,319 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:53 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
2,017 | $2.01 | 59,741 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:51 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Hanson Kristopher VP, Head of Legal |
1,545 | $2.01 | 3,632 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:50 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
5,766 | $2.01 | 0 (Direct) |
View |
| 2021-11-08 Option Award |
2021-11-09 8:46 pm |
N/A 2031-11-08 |
PhaseBio Pharmaceuticals Inc | PHAS | Birchall Jonathan Chief Commercial Officer |
250,000 | $3.37 | 250,000 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-08 6:26 pm |
N/A 2028-05-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
24,860 | $2.26 | 43,416 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-08 6:26 pm |
N/A 2029-02-27 |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
8,900 | $3.15 | 43,416 (Direct) |
View |
| 2021-11-03 Exercise |
2021-11-03 7:30 pm |
2018-10-08 2024-11-04 |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
20,000 | $1.24 | 275,617 (Direct) |
View |
| 2021-11-03 Exercise |
2021-11-03 7:30 pm |
2020-04-11 2026-05-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $1.68 | 148,306 (Direct) |
View |